絞り込み

16406

広告

原子炉建屋想定し高専生技術競う (デイリースポーツ)

東京電力福島第1原発の原子炉建屋を想定した会場で、高専生が自作ロボットの操作技術を競う「廃炉創造ロボコン」が16日、福島県楢葉町で開かれた。廃炉技術に興味を持っ...

  1. [企業] Andreessen Horo...
  2. 金井さん、17日宇宙へ (デイリースポー...
  3. 宇宙飛行士の金井さん あす打ち上げ 長期...
  4. [企業] Relay社 蛋白質の動きの理...

ニュース一覧

「"Lacouture ME"[Author]」の検索結果

182件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.

A survey of patient and physician acceptance of skin toxicities from anti-epidermal growth factor receptor therapies.

Granuloma annulare associated with immune checkpoint inhibitors.

Scalp hypothermia as a preventative measure for chemotherapy-induced alopecia: A review of controlled clinical trials.

Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis.

Olmutinib-induced palmoplantar keratoderma.

Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade: Clinicopathologic Analysis of the Nonlichenoid Histologic Pattern.

Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosis.

Post-reconstruction dermatitis of the breast.

Eruptive Keratoacanthomas Associated With Pembrolizumab Therapy.

Oral Lichenoid Reactions associated with anti-PD-1/PD-L1 therapies: clinicopathological findings.

Impact of a planned dose interruption of dacomitinib in the treatment of advanced non-small-cell lung cancer (ARCHER 1042).

A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel.

Treatment (Tx) guidelines for skin and mucosal events in patients with solid tumors (pts) receiving TH-302, a tumor selective, hypoxia-activated prodrug.

Development and validation of a prediction tool for hand-foot skin reaction (HFSR) in patients receiving sorafenib.

Management of dermatologic toxicities associated with epidermal growth factor inhibitors (EGFRIs) and multikinase inhibitors (MKIs).

Quality of life in patients with dermatologic toxicities: Experience from the SERIES clinic.

Scarring, disfigurement, and quality of life in long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります